Skip to main content
Back
Watch Compare

DiaMedica Therapeutics Inc.

Data quality: 83%
DMAC
Nasdaq Manufacturing Chemicals
$5.99
▼ $0.19 (-3.07%)
Mkt Cap: 335.15 M
Price
$6.22
Mkt Cap
335.15 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -29.10 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-83.17%
Below sector avg (-53.34%)
ROIC-68.68%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio10.67
Interest CoverageN/A

Valuation

PE (TTM)
-10.23
Below sector avg (-1.47)
P/B Ratio6.49
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -10.2 -1.5
P/B 6.5 1.6
ROE % -83.2 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

4 analysts
Buy
Current
$5.99
+158.8%
Target
$15.50
$11.00
$13.00
$25.00
Forecast
Forward P/E -7.17
Forward EPS -$0.84
Est. Revenue 3.11 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.84
-$1.05 – -$0.62
 3.11 M 5
FY2026 -$0.80
-$0.92 – -$0.69
 0.0 4

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.18 -$0.17 +5.6%
Q32025 -$0.16 -$0.17 -6.3%
Q22025 -$0.19 -$0.18 +5.3%
Q12025 -$0.18 -$0.18 0.0%

ETFs Holding This Stock

JMIGX JMIGX
3.85% weight
JMCGX JMCGX
3.85% weight
VVICX VVICX
0.01% weight
IRCIX IRCIX
0.01% weight
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRSSX IRSSX
0.01% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -32.77 M
ROE -83.17% ROA -74.03%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -29.10 M
ROIC -68.68% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10.67
Interest Coverage N/A Asset Turnover N/A
Working Capital 50.96 M Tangible Book Value 51.62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10.23 Forward P/E N/A
P/B Ratio 6.49 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.68%
Market Cap 335.15 M Enterprise Value 331.82 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.54 OCF / Share -0.54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88.82%
SBC-Adj. FCF -32.32 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -32.77 M -24.44 M -19.38 M -13.68 M -13.59 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -34.40 M -26.68 M -21.27 M -14.00 M -13.65 M
EBITDA — — — — —
R&D Expenses 24.61 M 19.06 M 13.11 M 7.84 M 8.77 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 28,000.0 30,000.0 43,000.0 28,000.0 28,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 61.37 M 46.35 M 54.16 M 34.40 M 45.55 M
Total Liabilities — — — — —
Shareholders' Equity 56.11 M 40.72 M 51.06 M 31.83 M 44.02 M
Total Debt — — — — —
Cash & Equivalents 15.65 M 3.03 M 4.54 M 4.73 M 4.71 M
Current Assets 60.63 M 44.61 M 53.68 M 33.84 M 45.44 M
Current Liabilities 5.13 M 5.39 M 2.79 M 2.17 M 1.52 M